Almac Group Expands Asia Pacific Presence

July 10, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

Almac Group announced the successful completion of the Health Sciences Authority (HSA) inspection of its new Asia Pacific headquarters in Singapore.

 

Almac Group announced the successful completion of the Health Sciences Authority (HSA) inspection of its new Asia Pacific headquarters in Singapore. The new facility expands on Almac's suite of clinical trial primary and secondary packaging, distribution, technology and consultation solutions offered from within the region. According to Almac’s president and managing director of Almac’s Clinical Services business unit noted 23% of global clinical trials are being conducted in Asia Pacific.

 

Read the full release here.

Related Content:

News